Home LiteratureArticle Details
PMID: 9502080 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Over-expression of human CD44s in murine 3T3 cells: selection against during primary tumorigenesis and selection for during micrometastasis.

Clinical & experimental metastasis ·Vol. 16 ·No. 1 ·1998-01-00 ·Pages 83-93

Kogerman P, Sy MS, Culp LA

Abstract

Human CD44 standard isoform (hCD44s) cDNA regulated by a high-expressing promoter was transfected into Balb/c 3T3 cells and the tumorigenic and metastatic capacities of the transfectants were investigated in nude mice at the subcutaneous site. One of three transfectants was tumorigenic. hCD44s expression was lost in the cells of large primary tumors using this tumorigenic clone. These tumors were extremely aggressive giving overt metastases and micrometastases to several sites including mesentery, stomach, liver, diaphragm, pancreas and lung. Micrometastatic cells re-expressed hCD44s, consistent with its importance for early steps in the metastatic cascade. hCD44s was not expressed in overt metastases; most probably the expression was lost during the outgrowth of micrometastases into overt metastatic tumors. Thus hCD44s expression in murine 3T3 cells does induce tumorigenicity in select cases, is not compatible with aggressive outgrowth of primary or secondary tumors, and is advantageous for early steps in metastatic spread. These results suggest that CD44s is an example of a novel type of 'metastasis' molecule that is disadvantageous for tumor growth and is only transiently advantageous during metastatic spreading of tumor cells to distant organs.

MeSH Terms
3T3 Cells/metabolism,pathology Animals Cell Transformation, Neoplastic/metabolism Disease Progression Flow Cytometry Humans Hyaluronan Receptors/genetics,metabolism Mice Mice, Inbred BALB C Mice, Nude Neoplasm Metastasis Transfection
Chemicals
Hyaluronan Receptors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kogerman P
Department of Molecular Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
Sy M S
Culp L A
References (34)
34 references, click to expand
  1. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway.
    J Exp Med. 1996 Mar 1;183(3):1119-30 PMID: 8642254
  2. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Cell Immunol. 1993 Nov;152(1):186-99 PMID: 7694807
  3. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
    J Cell Physiol. 1994 Aug;160(2):275-86 PMID: 7518822
  4. Upregulation of CD44s in c-sis-transformed balb/c 3T3 cells by autocrine growth factor mechanisms, including PDGF.
    Int J Oncol. 1997 Mar;10(3):553-60 PMID: 21533412
  5. Altered expression of CD44 in human prostate cancer during progression.
    Am J Clin Pathol. 1996 Nov;106(5):647-51 PMID: 8929476
  6. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells.
    Oncogene. 1994 Feb;9(2):417-23 PMID: 7507229
  7. Angiogenesis in cancer, vascular, rheumatoid and other disease.
    Nat Med. 1995 Jan;1(1):27-31 PMID: 7584949
  8. Distinct effects of two CD44 isoforms on tumor growth in vivo.
    J Exp Med. 1991 Oct 1;174(4):859-66 PMID: 1919439
  9. Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.
    Br J Cancer. 1993 May;67(5):910-21 PMID: 8494724
  10. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression.
    Proc Natl Acad Sci U S A. 1987 Aug;84(15):5143-7 PMID: 3474646
  11. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Cancer Res. 1994 Jul 15;54(14):3922-8 PMID: 7518345
  12. Significance of CD44 gene products for cancer diagnosis and disease evaluation.
    Lancet. 1992 Oct 31;340(8827):1053-8 PMID: 1357452
  13. Topological and quantitative-analyses of early events in tumor-formation using histochemically-tagged transformed 3t3 cells.
    Oncol Rep. 1994 Sep;1(5):869-76 PMID: 21607457
  14. Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model.
    Oncogene. 1997 Sep 18;15(12):1407-16 PMID: 9333016
  15. Angiogenesis induced by degradation products of hyaluronic acid.
    Science. 1985 Jun 14;228(4705):1324-6 PMID: 2408340
  16. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo.
    Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7832-7 PMID: 8755562
  17. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Cancer Res. 1993 Sep 15;53(18):4197-203 PMID: 7689929
  18. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.
    Cell. 1991 Apr 5;65(1):13-24 PMID: 1707342
  19. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Cancer Res. 1993 Apr 1;53(7):1516-21 PMID: 8453616
  20. CD44: the hyaluronan receptor.
    J Cell Sci. 1992 Oct;103 ( Pt 2):293-8 PMID: 1282514
  21. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Cancer Res. 1988 Sep 1;48(17):4941-53 PMID: 3409227
  22. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis.
    Exp Cell Res. 1993 Feb;204(2):171-80 PMID: 8382620
  23. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family.
    Cell. 1989 Mar 24;56(6):1057-62 PMID: 2466575
  24. CD44 and its interaction with extracellular matrix.
    Adv Immunol. 1993;54:271-335 PMID: 8379464
  25. Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence.
    Clin Exp Metastasis. 1996 Jan;14(1):73-82 PMID: 8521619
  26. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning.
    Development. 1993 Oct;119(2):295-306 PMID: 7507029
  27. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
    Cancer Res. 1991 Oct 1;51(19):5292-7 PMID: 1717145
  28. High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes.
    Am J Pathol. 1992 Dec;141(6):1331-42 PMID: 1466397
  29. CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene.
    J Cell Physiol. 1996 Nov;169(2):341-9 PMID: 8908201
  30. Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression.
    Cancer Res. 1990 May 1;50(9):2808-17 PMID: 2183931
  31. Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression.
    Int J Cancer. 1991 Apr 22;48(1):148-59 PMID: 2019453
  32. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures.
    J Exp Med. 1990 Feb 1;171(2):477-88 PMID: 2406365
  33. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.
    J Cell Biol. 1992 Feb;116(4):1055-62 PMID: 1370836
  34. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Cancer Res. 1994 Mar 15;54(6):1561-5 PMID: 7511044
Article Info
Journal
Clinical & experimental metastasis
Abbr.
Clin Exp Metastasis
ISSN
0262-0898
Published
1998-01-00
Pages
83-93
Language
English
Region
Netherlands
NLM ID
8409970
Subset
IM
Grants
NCI NIH HHS · CA27755 · United States
NCI NIH HHS · CA60469 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com